-
Beijing embraces DeepSeek to lead AI adoption as it looks for new growth drivers
DeepSeek's rise came as a timely confidence boost as the Chinese leadership faces a prolonged economic gloom and a brewing trade war with U.S.CNBC - 7h -
Accused UnitedHealthcare CEO killer to appear in New York court
Luigi Mangione, the man accused of gunning down UnitedHealthcare CEO Brian Thompson, is expected to appear in a New York courtroom on Friday. The 26-year-old is charged with first degree murder. ...CBS News - 6h -
New Scotland-England border landmark plan submitted
The Star of Caledonia will stand 33m (100ft) high and aim to attract hundreds of thousands of visitors.BBC News - 15h -
Scientists Describe Rare Syndrome Following Covid Vaccinations
In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high levels of a coronavirus protein.The New York Times - 6h -
Stocks tumble as Walmart sales growth forecast disappoints
Stocks tumbled from all-time highs Thursday in the wake of Walmart projecting a lower-than-expected sales outlook.NBC News - 23h -
Ex-Deputy Describes Rampant Violence by Mississippi ‘Goon Squad’
From a prison cell, one former deputy recounted how illegal searches and brutal beatings were used for years to help make drug convictions in his suburban county.The New York Times - 10h -
Nike and Kim Kardashian to Launch ‘NikeSkims’ Brand in the Spring
The Skims founder will enter into a rare business deal with the sports apparel company.The New York Times - 3d -
Meghan Markle Renames Her Lifestyle Brand As Ever
In an Instagram video posted ahead of her upcoming Netflix series, the Duchess of Sussex announced her brand’s new name and its revamped focus.The New York Times - 2d -
Hayley Paige Reclaims Her Name and Bridal Brand
After a long legal battle that stripped her of her name and brand, the bridal designer is making a return to the industry with a new collection and a new deal.The New York Times - 1d
More from CNBC
-
Steve Cohen says tariffs and DOGE's cuts are negative for economy, market correction could be soon
The CEO of hedge fund Point72 turned bearish for the first time in a while due to punitive tariffs, immigration crackdown and federal spending cuts.CNBC - 37m -
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its subsidiary and high medical costs.CNBC - 20m -
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortageCNBC - 14m -
Home sales drop sharply as prices hit an all-time high for January
The median price of a home sold in January was $396,900, up 4.8% from the year before and the highest price ever for the month of January.CNBC - 4h -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 20m
More in Business
-
Coinbase says the SEC has agreed to end 'bogus' enforcement case against crypto exchange
The announcement comes as the regulator is expected to be more friendly to crypto under President Donald Trump.CNBC - 8m -
President Trump should combine extending tax cuts with fixing Social Security
It would be good fiscal policy and probably good politicsMarketWatch - 12m -
‘I feel like I’ve opened a hornet’s nest’: My mother-in-law lists my husband as beneficiary on her $1 million IRA. But her will says otherwise. Who wins?
“All of this is causing a lot of turmoil in the family. Does her will trump the IRA beneficiary?”MarketWatch - 14m -
US stocks post worst slide in two months on gloomy economic data
Sentiment among businesses and consumers cools sharply as tariffs and inflation take a tollFinancial Times - 14m -
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortageCNBC - 14m